Cost-Effectiveness of ApoB, Non-HDL-C, and LDL-C Goals for Primary Prevention Lipid-Lowering Therapy.
Saved in:
| Title: | Cost-Effectiveness of ApoB, Non-HDL-C, and LDL-C Goals for Primary Prevention Lipid-Lowering Therapy. |
|---|---|
| Authors: | Luebbe S; Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois., Sniderman AD; Mike and Valeria Rosenbloom Center for Cardiovascular Prevention, Division of Cardiology, McGill University Health Center, Montreal, Quebec, Canada., Moran AE; Division of General Medicine, Columbia University Irving Medical Center, New York, New York., Wilkins JT; Division of Cardiology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.; Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois., Kohli-Lynch CN; Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois. |
| Source: | JAMA [JAMA] 2026 May 05; Vol. 335 (17), pp. 1507-1514. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN: 1538-3598 (Electronic) Linking ISSN: 00987484 NLM ISO Abbreviation: JAMA Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
